3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
5
Thoracic
2
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
84
Triple Negative Breast Neoplasms
24
Neoplasm Metastasis
9
Breast Neoplasms, Male
8
Carcinoma, Intraductal, Noninfiltrating
7
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Melanoma
5
Colorectal Neoplasms
5
Breast Carcinoma In Situ
5
Uterine Cervical Neoplasms
4
Prostatic Neoplasms
4
Inflammatory Breast Neoplasms
4
Endometrial Neoplasms
4
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Salivary Gland Neoplasms
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Anatomic Stage IV Breast Cancer AJCC v8
3
Thyroid Neoplasms
2
Skin Neoplasms
2
Sarcoma
2
Rectal Neoplasms
2
Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Lung Neoplasms
2
Interventions
pembrolizumab
18
Nivolumab
12
atezolizumab
5
Ipilimumab
4
Cyclophosphamide
4
fludarabine
3
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Fluorodeoxyglucose F18
3
Docetaxel
3
Carboplatin
3
spartalizumab
2
cabozantinib
2
avelumab
2
aldesleukin
2
Specimen Handling
2
Interleukin-2
2
Immunoglobulin G
2
zanidatamab
1
veliparib
1
trastuzumab deruxtecan
1
tislelizumab
1
temsirolimus
1
sargramostim
1
sacituzumab govitecan
1
rucaparib
1
regorafenib
1
poly ICLC
1
pemigatinib
1
liposomal doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Biopsy
×
Breast
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled